Pancreatic hypoplasia-diabetes-congenital heart disease syndrome: A Patient Guide
At a Glance
GATA6-related disorder is a rare genetic condition that can affect the heart and pancreas, leading to congenital heart disease, diabetes, or digestive problems. Features vary widely, so treatment is tailored and may include insulin, pancreatic enzymes, and specialist monitoring.
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome is a rare genetic condition that affects the early development of several vital organ systems. Most often associated with a pathogenic variant in the GATA6 gene, this syndrome (often referred to as a GATA6-related disorder) serves as a reminder of how early genetic blueprints guide the construction of the heart and digestive organs [1].
The condition is characterized by three possible “pillars”: the heart, blood sugar regulation, and digestion. In the heart, the genetic change can disrupt the formation of major blood vessels and internal walls, leading to structural defects that are often present at birth [2]. At the same time, the pancreas—the organ responsible for making insulin and digestive juices—may be smaller than usual (hypoplasia) or missing entirely (agenesis) [3]. If the pancreas is severely affected, the body may not be able to maintain healthy blood sugar levels, leading to neonatal diabetes, nor can it properly break down fats and nutrients from food [4]. Importantly, this is a spectrum: not every person has congenital heart disease, diabetes at birth, or clinically significant digestive issues.
One of the most important things to understand about this syndrome is its variable expressivity, or the “dimmer switch” effect. Even within the same family, two people with the exact same genetic variant may have very different experiences [5]. One person might be born with a complex heart defect and early-onset diabetes, while another might have only a mild heart murmur or develop diabetes much later in adulthood [6]. Because the syndrome is so rare, it is normal to find that local doctors have limited experience with it, making it essential to connect with a specialized care team that understands these unique patterns [7].
Living with this condition is focused on monitoring the organs that need support and replacing what the body cannot produce on its own. This typically involves insulin therapy if diabetes is diagnosed, and pancreatic enzyme replacement when digestive insufficiency is demonstrated [8]. While the diagnosis is complex, modern medicine allows specialists to tailor treatments to your child’s—or your own—specific needs, so that individuals with this syndrome can thrive [4].
In this guide
6 chapters
Understanding GATA6 Syndrome and Pancreatic Agenesis
Learn how GATA6 syndrome affects the pancreas, heart, and digestion, including diabetes, pancreatic enzyme deficiency, genetic inheritance, and long-term care.
Genetics, Inheritance, and Biological Diagnosis
Learn how GATA6 syndrome affects pancreas and heart development, how it is inherited, and how genetic testing and imaging help confirm the diagnosis in your child.
Managing Neonatal Diabetes and Exocrine Pancreatic Insufficiency
Learn how GATA6 syndrome affects neonatal diabetes and exocrine pancreatic insufficiency: enzyme therapy, insulin, nutrition, monitoring, and emergency signs.
Navigating Congenital Heart Defects
Learn how GATA6 syndrome can affect the heart, which defects and warning signs to know, how doctors evaluate them, and why lifelong cardiology follow-up matters.
Building Your Child's Multidisciplinary Care Team
Learn how families coordinate GATA6 syndrome care, from endocrine, heart, and digestive specialists to shared records, insulin planning, and emergency support.
Long-term Surveillance and Associated Conditions
Learn how GATA6 syndrome affects the thyroid, kidneys, and bile ducts, plus growth, vitamin, bone, heart, and diabetes monitoring during long-term follow-up.
Common questions in this guide
What is pancreatic hypoplasia-diabetes-congenital heart disease syndrome?
Does everyone with a GATA6-related disorder have heart defects and diabetes?
What treatments are used when the pancreas is affected?
Why might my child need several specialists?
Should family members have genetic testing?
What should be monitored over time?
Get notified when new evidence is published on Pancreatic hypoplasia-diabetes-congenital heart disease syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.
Chia CY, Madrigal P, Denil SLIJ, et al.
Stem cell reports 2019; (12(1)):57-70 doi:10.1016/j.stemcr.2018.12.003.
PMID: 30629940 - 2
Congenital hypothyroidism, cardiac defects, and pancreatic agenesis in an infant with GATA6 mutation.
Raghuram N, Marwaha A, Greer MC, et al.
American journal of medical genetics. Part A 2020; (182(6)):1496-1499 doi:10.1002/ajmg.a.61569.
PMID: 32207556 - 3
Case report: adult onset diabetes with partial pancreatic agenesis and congenital heart disease due to a de novo GATA6 mutation.
Sanchez-Lechuga B, Saqlain M, Ng N, et al.
BMC medical genetics 2020; (21(1)):70 doi:10.1186/s12881-020-01012-2.
PMID: 32245430 - 4
The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes.
Sechko EA, Koltakova MP, Khusainova RI, et al.
International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252211998.
PMID: 39596087 - 5
Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus.
Yau D, De Franco E, Flanagan SE, et al.
Diagnostic pathology 2017; (12(1)):1 doi:10.1186/s13000-016-0592-1.
PMID: 28049534 - 6
Monogenic Diabetes with GATA6 Mutations: Characterization of a Novel Family and a Comprehensive Analysis of the GATA6 Clinical and Genetics Traits.
Yue X, Luo Y, Wang J, Huang D
Molecular biotechnology 2024; (66(3)):467-474 doi:10.1007/s12033-023-00761-8.
PMID: 37204622 - 7
A novel GATA6 variant in a boy with neonatal diabetes and diaphragmatic hernia: a familial case with a review of the literature.
Gaisl O, Konrad D, Joset P, Lang-Muritano M
Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(9)):1027-1030.
PMID: 31271559 - 8
Successful Treatment of a Very Low-Birth-Weight Infant With GATA6 Neonatal Diabetes Using Continuous Subcutaneous Insulin Infusion.
Ito T, Suzuki A, Yamaguchi N, et al.
Cureus 2025; (17(5)):e83555 doi:10.7759/cureus.83555.
PMID: 40476119
This page explains GATA6-related pancreatic, heart, blood-sugar, and digestive features for informational purposes only; it does not constitute medical advice. Ask your genetics, cardiology, diabetes, and digestive-care team to interpret your or your child’s findings and treatment needs.